{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:20:52Z","timestamp":1784996452490,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10157-018-1543-9","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:03:52Z","timestamp":1519430632000},"page":"1188-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients?"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-9704","authenticated-orcid":false,"given":"Elin","family":"Isaksson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Almquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Sterner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,24]]},"reference":[{"key":"1543_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","volume":"Suppl 113","author":"Kidney Disease: Improving Global Outcomes CKDMBDWG","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009;Suppl 113:S1\u2013130. \n                    https:\/\/doi.org\/10.1038\/ki.2009.188\n                    \n                  .","journal-title":"Kidney Int"},{"issue":"7","key":"1543_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2215\/CJN.10370915","volume":"11","author":"SM Kim","year":"2016","unstructured":"Kim SM, Long J, Montez-Rath ME, Leonard MB, Norton JA, Chertow GM. Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States. Clin J Am Soc Nephrol. 2016;11(7):1260\u20137. \n                    https:\/\/doi.org\/10.2215\/CJN.10370915\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"1543_CR3","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2215\/CJN.04260413","volume":"8","author":"GA Block","year":"2013","unstructured":"Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol. 2013;8(12):2132\u201340. \n                    https:\/\/doi.org\/10.2215\/CJN.04260413\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1543_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","volume":"38","author":"MM Avram","year":"2001","unstructured":"Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2001;38(6):1351\u20137. \n                    https:\/\/doi.org\/10.1053\/ajkd.2001.29254\n                    \n                  .","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1543_CR5","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00198-016-3636-1","volume":"27","author":"SA Lee","year":"2016","unstructured":"Lee SA, Lee MJ, Ryu GW, Jhee JH, Kim HW, Park S, et al. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients. Osteoporo Int. 2016;27(9):2717\u201326. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3636-1\n                    \n                  .","journal-title":"Osteoporo Int"},{"issue":"8","key":"1543_CR6","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208\u201318. \n                    https:\/\/doi.org\/10.1097\/01.ASN.0000133041.27682.A2\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"1\u20132","key":"1543_CR7","doi-asserted-by":"publisher","first-page":"c68","DOI":"10.1159\/000342811","volume":"121","author":"E Isaksson","year":"2012","unstructured":"Isaksson E, Sterner G. Early development of secondary hyperparathyroidism following renal transplantation. Nephron Clin Pract. 2012;121(1\u20132):c68\u201372. \n                    https:\/\/doi.org\/10.1159\/000342811\n                    \n                  .","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"1543_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant. 2004;19(5):1281\u20137. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfh128\n                    \n                  .","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1543_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1681\/ASN.2010080894","volume":"22","author":"M Wolf","year":"2011","unstructured":"Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol. 2011;22(5):956\u201366. \n                    https:\/\/doi.org\/10.1681\/ASN.2010080894\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1543_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000000583","volume":"99","author":"H Pihlstrom","year":"2015","unstructured":"Pihlstrom H, Dahle DO, Mjoen G, Pilz S, Marz W, Abedini S, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351\u20139. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000000583\n                    \n                  .","journal-title":"Transplantation"},{"issue":"7","key":"1543_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/00365510701326891","volume":"67","author":"J Bjork","year":"2007","unstructured":"Bjork J, Back SE, Sterner G, Carlson J, Lindstrom V, Bakoush O, et al. Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest. 2007;67(7):678\u201395. \n                    https:\/\/doi.org\/10.1080\/00365510701326891\n                    \n                  .","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"1543_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/00365510410002832","volume":"64","author":"A Martensson","year":"2004","unstructured":"Martensson A, Rustad P, Lund H, Ossowicki H. Creatininium reference intervals for corrected methods. Scand J Clin Lab Invest. 2004;64(4):439\u201341. \n                    https:\/\/doi.org\/10.1080\/00365510410002832\n                    \n                  .","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"1543_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/00365510410006324","volume":"64","author":"P Rustad","year":"2004","unstructured":"Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest. 2004;64(4):271\u201384. \n                    https:\/\/doi.org\/10.1080\/00365510410006324\n                    \n                  .","journal-title":"Scand J Clin Lab Invest"},{"issue":"10","key":"1543_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1432-2277.2008.00717.x","volume":"21","author":"J Aalten","year":"2008","unstructured":"Aalten J, Hoogeveen EK, Roodnat JI, Weimar W, Borm GF, de Fijter JW, et al. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transplant Int. 2008;21(10):985\u201391. \n                    https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00717.x\n                    \n                  .","journal-title":"Transplant Int"},{"issue":"3","key":"1543_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/01.tp.0000228923.75739.88","volume":"82","author":"JI Roodnat","year":"2006","unstructured":"Roodnat JI, van Gurp EA, Mulder PG, van Gelder T, de Rijke YB, de Herder WW, et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation. 2006;82(3):362\u20137. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000228923.75739.88\n                    \n                  .","journal-title":"Transplantation"},{"issue":"9","key":"1543_CR16","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.transproceed.2012.09.041","volume":"44","author":"R Marcen","year":"2012","unstructured":"Marcen R, Jimenez S, Fernandez A, Galeano C, Villafruela JJ, Burgos FJ, et al. The effects of mineral metabolism markers on renal transplant outcomes. Transplant Proc. 2012;44(9):2567\u20139. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2012.09.041\n                    \n                  .","journal-title":"Transplant Proc"},{"issue":"4","key":"1543_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ctr.12341","volume":"28","author":"IH Bleskestad","year":"2014","unstructured":"Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Goransson LG. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant. 2014;28(4):479\u201386. \n                    https:\/\/doi.org\/10.1111\/ctr.12341\n                    \n                  .","journal-title":"Clin Transplant"},{"issue":"2","key":"1543_CR18","doi-asserted-by":"publisher","first-page":"c211","DOI":"10.1159\/000321642","volume":"118","author":"G Jean","year":"2011","unstructured":"Jean G, Lataillade D, Genet L, Legrand E, Kuentz F, Moreau-Gaudry X, et al. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort. Nephron Clin Pract. 2011;118(2):c211\u20136. \n                    https:\/\/doi.org\/10.1159\/000321642\n                    \n                  .","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"1543_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","volume":"61","author":"HM Alshayeb","year":"2013","unstructured":"Alshayeb HM, Josephson MA, Sprague SM. CKD-mineral and bone disorder management in kidney transplant recipients. Am J Kidney Dis. 2013;61(2):310\u201325. \n                    https:\/\/doi.org\/10.1053\/j.ajkd.2012.07.022\n                    \n                  .","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1543_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/nep.12570","volume":"21","author":"C Carvalho","year":"2016","unstructured":"Carvalho C, Magalhaes J, Pereira L, Simoes-Silva L, Castro-Ferreira I, Frazao JM. Evolution of bone disease after kidney transplantation: a prospective histomorphometric analysis of trabecular and cortical bone. Nephrology. 2016;21(1):55\u201361. \n                    https:\/\/doi.org\/10.1111\/nep.12570\n                    \n                  .","journal-title":"Nephrology"},{"issue":"5","key":"1543_CR21","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","volume":"63","author":"E Rojas","year":"2003","unstructured":"Rojas E, Carlini RG, Clesca P, Arminio A, Suniaga O, De Elguezabal K, et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 2003;63(5):1915\u201323. \n                    https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00938.x\n                    \n                  .","journal-title":"Kidney Int"},{"issue":"11","key":"1543_CR22","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","volume":"26","author":"JB Cannata-Andia","year":"2011","unstructured":"Cannata-Andia JB, Roman-Garcia P, Hruska K. The connections between vascular calcification and bone health. Nephrol Dial Transplant. 2011;26(11):3429\u201336. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfr591\n                    \n                  .","journal-title":"Nephrol Dial Transplant"},{"key":"1543_CR23","doi-asserted-by":"publisher","first-page":"7126290","DOI":"10.1155\/2016\/7126290","volume":"2016","author":"T Amin","year":"2016","unstructured":"Amin T, Coates PT, Barbara J, Hakendorf P, Karim N. Prevalence of hypercalcaemia in a renal transplant population: a single centre study. Int J Nephrol. 2016;2016:7126290. \n                    https:\/\/doi.org\/10.1155\/2016\/7126290\n                    \n                  .","journal-title":"Int J Nephrol"},{"issue":"2","key":"1543_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000151292","volume":"29","author":"SM Lee","year":"2009","unstructured":"Lee SM, Lee AL, Winters TJ, Tam E, Jaleel M, Stenvinkel P, et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol. 2009;29(2):79\u201385. \n                    https:\/\/doi.org\/10.1159\/000151292\n                    \n                  .","journal-title":"Am J Nephrol"},{"issue":"3","key":"1543_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000346846","volume":"37","author":"F Duranton","year":"2013","unstructured":"Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daures JP, Argiles A. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol. 2013;37(3):239\u201348. \n                    https:\/\/doi.org\/10.1159\/000346846\n                    \n                  .","journal-title":"Am J Nephrol"},{"issue":"4","key":"1543_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5500\/wjt.v5.i4.231","volume":"5","author":"PT Taweesedt","year":"2015","unstructured":"Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant. 2015;5(4):231\u201342. \n                    https:\/\/doi.org\/10.5500\/wjt.v5.i4.231\n                    \n                  .","journal-title":"World J Transplant"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1543-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T15:23:35Z","timestamp":1553700215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1543-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,24]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1543-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,24]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no financial or other conflicts of interest. The results in this paper have not been published previously in whole or part except in abstract format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (DNR 2011\/603) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}